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CalciumBap31 is an integral ER membrane protein which functions as an escort factor in the sorting of newly synthesized
membrane proteins within the endoplasmic reticulum (ER). During apoptosis signaling, Bap31 is subject to early
cleavage by initiator caspase-8. The resulting p20Bap31 (p20) fragment has been shown to initiate proapoptotic
ER-mitochondria Ca2+ transmission, and to exert dominant negative (DN) effects on ER protein trafﬁcking. We
now report that ectopic expression of p20 in E1A/DNp53-transformed baby mouse kidney epithelial cells initiates
a non-apoptotic form of cell death with paraptosis-like morphology. This pathway was characterized by an early
rise in ER Ca2+ stores andmassive dilation of the ER/nuclear envelope, dependent on intact ER Ca2+ stores. Ablation
of the Bax/Bak genes had no effect on these ER/nuclear envelope transformations, and delayed but did not prevent
cell death. ER-restricted expression of Bcl2 in the absence of Bax/Bak, however, delayed both ER/nuclear envelope
dilation and cell death. This prosurvival role of Bcl2 at the ER thus extended beyond inhibition of Bax/Bak, and cor-
relatedwith its ability to lower ER Ca2+ stores. Furthermore, these results indicate that ER restricted Bcl2 is capable
of antagonizing not only apoptosis, but also a non-apoptotic, Bax/Bak independent, paraptosis-like form of cell
death.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Bap31, an endoplasmic reticulum (ER) localized polytopic trans-
membrane (TM) protein, plays a variety of roles in trafﬁcking and
quality control within the secretory system. Bap31 has been shown
to function in ER retention/retrieval, cell surface export, survival/
stabilization and ER associated degradation (ERAD) of select TM pro-
teins [1–11]. Consistent with these disparate effects on ER protein
trafﬁcking is our recent ﬁnding that Bap31 associates with the
Sec61 preprotein translocon at the ER, interacts with nascent client
proteins as they emerge from the translocon, and escorts client pro-
teins to ER complexes which determine their subsequent fate [9].
In addition to its role in protein trafﬁcking, Bap31 also provides
resistance to cytoplasmic events associated with membrane frag-
mentation in response to select apoptotic stimuli [12–14]. A number
of apoptotic pathways involve cleavage of Bap31 by caspase-8; an
event which both abrogates its antiapoptotic function and generates
a membrane-embedded proapoptotic fragment, p20Bap31, or p20
[1,12,15–26]. Of note, ectopic expression of p20 was shown to in-
duce apoptosis even in the absence of endogenous Bap31 [15].try, McIntyre Medical Sciences
anada, H3G 1Y6. Tel.: +1 514
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rights reserved.p20 can also exert dominant negative (DN) interference with the
protein transport functions of full-length Bap31 [1,4,9]. The inﬂuence
of Bap31 or p20 in a particular cellular background, however, is likely
dependent on the cargo protein under study, the relative levels of
Bap31/p20 interacting partners, and the cell death competence of
the system.
Wehave previously shown that p20 provides a proapoptotic signal via
mobilization of ER Ca2+ stores. Ca2+ released from the ER is subsequently
taken up by themitochondria, leading to organelle ﬁssion. This alteration
in mitochondrial morphology, which is likely accompanied by cristae
remodeling, is thought to act as a “sensitizing signal” for release of the
proapoptotic factor cytochrome c, allowing efﬁcient mobilization of this
molecule following mitochondrial outer membrane permeabilization
(MOMP) [15,27]. Under physiological conditions, where apoptosis typi-
cally involves the induction of multiple pro-death proteins, Bap31 cleav-
age likely functions primarily as an ampliﬁcation or sensitization signal,
with another (mitochondrial) signal being directly responsible for
MOMP. Nevertheless, prolonged ectopic expression of p20 does eventual-
ly lead to cell death [15].
Apoptosis associated with mitochondrial release of cytochrome c
is, in most cases, regulated by the Bcl2 family of proteins [28]. The
Bcl2 family consists of both pro- and anti-apoptotic members,
where the proapoptotic multidomain Bcl2 proteins (Bax/Bak), act to
permeabilize the outer mitochondrial membrane, leading to release
of intermembrane proapoptotic factors, including cytochrome c. The
antiapoptotic Bcl2 proteins act, both directly and indirectly, to inhibit
Bax/Bak. The proapoptotic “BH3-only” Bcl2 proteins either inhibit the
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Bcl2 family members have been best studied with respect to their
role at the mitochondria, they are also present at the ER, where
they act, at least in part, to regulate ER Ca2+ stores and/or signaling
[31–33].
Induction of Ca2+ release from the ER and ensuing apoptosis follow-
ing p20 expression is likely regulated by Bcl2 proteins, as cell death was
preceded by Bax activation, and could be inhibited by overexpression of
either wild-type or ER-restricted Bcl2 (Bcl2b5) [15]. Additional support
for the potential involvement of Bcl2 proteins in this pathway was pro-
vided by our study of the ER localized BH3-only protein Bik. Bik initiates
a pathway similar to that seen for p20, and, in this system, both ER Ca2+
release and downstream mitochondrial events were shown to involve
Bax/Bak, and could be inhibited by either Bcl2 or Bcl2b5 [34,35].
In our attempts to further explore the roles of Bax and Bak in the
p20-induced cell death pathway, we used wild type (WT) and Bax/
Bak double knockout (DKO) baby mouse kidney (BMK) immortalized
epithelial cell lines, transformed by E1A and DN p53 [36]. We found,
unexpectedly, that expression of p20 led to initiation of a non-
apoptotic, paraptosis-like cell death pathway, in both WT and Bax/
Bak DKO BMK cells. This p20-initiated pathway was characterized
by an early rise, as opposed to release, of ER Ca2+ stores, as well as
an early and dramatic dilation of the ER/nuclear envelope (NE).
Thus the response to p20 expression can be dramatically different,
dependent on cellular context.
Of particular importance, both p20-initiated cell death andERdilation
could be signiﬁcantly delayed by overexpression of Bcl2b5 in the Bax/Bak
DKO BMK cells. Bcl2 has been previously shown to function in a prosur-
vival capacity through inhibition of Bax/Bak, and our ﬁndings therefore
represent evidence of a novel, Bax/Bak independent, prosurvival role
for this protein at the ER.2. Materials and methods
2.1. Cell lines and culture conditions
E1A/DNp53-transformedWT and Bax/BakDKOBMK cellswere kindly
providedbyDr. EileenWhite, RutgersUniversity, NewBrunswick, NJ [36].
Cells were cultured at 37 °C in a humidiﬁed 5% CO2 atmosphere, in RPMI
1640 media (Gibco) supplemented with 10% heat-inactivated FBS,
10 mM HEPES and 1 mM NaPyruvate. Cells stably expressing HA-
Bcl2b5 in pcDNA3.1/Hygro(−) (Invitrogen) were maintained in media
supplemented with 0.4 mg/ml hygromycin B (Invitrogen).2.2. Constructs and gene expression
HA-p20, Flag-Bap31, Flag-crBap31, HA-A4, HA-Bik and HA-Bcl2b5
constructs were all expressed in either pcDNA3.0 or pcDNA3.1 (Invitro-
gen), andhavebeenpreviously described [12,13,15,37,38]. Adenoviral ex-
pression vectors for HA-p20 (AdHA-p20), HA-Bik (AdHA-Bik) and rtTa
(AdrtTa) have also been previously described [15,37]. Bcl2b5 refers to
Bcl2 with the C-terminal membrane-targeting domain (aa 215–239)
replacedwith that of cytochromeb5 (aa107–134).HA-Bcl2b5was cloned
into pcDNA3.1/Hygro(−) (Invitrogen), and DKO cells stably expressing
HA-Bcl2b5 were obtained through transfection using Lipofectamine Plus
(Invitrogen), followed by selection of individual clones with hygromycin
B. As previously reported [39], Bcl2b5 was expressed at the ER, and not
at the mitochondria, as determined by immunoﬂuorescence microscopy
(data not shown).
Adenoviral infection was carried out as previously described, on
subconﬂuent cells, at the indicated MOI (multiplicity of infection, or
plaque-forming units (pfu)/cell) [15,37,38]. All transient transfec-
tions were carried out using Lipofectamine 2000 (Invitrogen), as per
manufacturer's instructions.2.3. Measurement of cell death, caspase activity and ER Ca2+ stores
Cellswere infectedwith the stated adenoviral expression constructs,
and both adherent and ﬂoating cells were collected at the indicated
times after infection. Cell death was determined through FACS analysis
of propidium iodide (PI) uptake. Cells were washed once with PBS, and
resuspended in PBS supplemented with 10 mg/ml propidium iodide
(PI). Uptake of PI was determined by analysis with a Becton Dickinson
FACScan Flow Cytometer. Samples were gated based on forward and
side scatter, and the percentage of PI positive cells was determined
based on intensity of ﬂuorescence detected in the FL2 channel. Where
indicated, infections were performed in the presence of ABT-737
(1 μM, GeminX) or zVAD-fmk (10 μM, MP Biomedicals). Caspase-3/7
activity was determined by measurement of DEVDase activity in
25 μg of cell lysate, as per manufacturer's instructions (Upstate Bio-
technology). Thapsigargin (TG) releasable ER Ca2+ stores were de-
termined using Fura2-AM (Molecular Probes), as previously
described [15,34].
2.4. Immunoﬂuorescence
Cells were seeded on glass coverslips and, where indicated,
infected with AdHA-p20 or transfected with HA-p20, HA-A4, Flag-
Bap31 or Flag-crBap31 expression vectors. Following ﬁxation in 4%
paraformaldehyde (PFA, Polysciences Inc), permeabilization anddouble
label immunoﬂuorescence staining were conducted as previously de-
scribed [15]. Coverslipsweremounted using ProLong Gold Antifade Re-
agent (Invitrogen), and images obtained using a Zeiss Axiovert 200
Inverted Microscope. Primary antibodies used were: mouse anti-HA
(Babco), mouse anti-Flag M2 (Sigma), goat anti-lactate dehydroge-
nase (LDH, Chemicon), and polyclonal rabbit anti-calnexin (kindly
provided by Dr. J. Bergeron, McGill University, Montreal, QC). Sec-
ondary antibodies used were: Alexa Fluor 488 or 594 conjugated
goat anti-rabbit, goat anti-mouse, or rabbit anti-goat (Molecular
Probes).
2.5. Light and electron microscopy
Phase contrast images were acquired using a Zeiss Axiovert 25
light-microscope, in combination with a Sony Cybershot DSC-S75
camera. For EM analysis, cells were grown in 10 cm2 tissue cul-
ture dishes, trypsinized, ﬁxed, and analyzed as previously de-
scribed [34]. In all cases both adherent and ﬂoating cells were
collected. For quantiﬁcation of ER vacuolization, the percentage
cellular area occupied by vacuolated ER/NE was determined
using ImageJ [40]. A minimum of 50 cells was analyzed per
condition.
2.6. Immunoprecipitation and Western blotting
For immunoprecipitation (IP) analysis, cells were infected with
adenoviral vector encoding the stated construct, for the indicated
times. Cells were solubilized at 4 °C in IP buffer (0.1% Triton X-100,
0.5% NP40, 50 mM HEPES-KOH, 150 mM NaCl, 1 mM EDTA pH7.5),
and the lysate was cleared by centrifugation for 10 min at
13000 ×g. Lysates were incubated overnight at 4 °C with 2 μl of ei-
ther hamster anti-humanBcl2 (anti-hBcl2) antibody (BD Pharmin-
gen), or normal hamster serum (NHS) as a negative control. 10 μl
of protein G-Sepharose (Amersham Biosciences) was added to the
samples, and they were incubated at 4 °C for an additional 2 h. The
beads were washed and then analyzed by Western blot using an
anti-HA antibody, for detection of HA-p20, HA-Bik and HA-Bcl2b5.
Lysis and IPs were done in the presence of protease inhibitors
(1 μg/ml each of leupeptin, aproptinin and pepstatin, and 1 μM
PMSF).
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SDS-PAGE, followed by transfer to nitrocellulose membrane and
detection with speciﬁc antibodies. Blots were incubated with
horseradish peroxidase (HRP)-conjugated secondary antibodiesFig. 1. Expression of p20, but not of Bik, leads to cell death even in the absence of Bax and Bak.
cleavage sites are indicated by asterisks. (B) p20 initiates cell death in bothWTand DKO cells, al
AdrtTa (control), at an MOI of 80, for the indicated times, and cell death was determined by FA
mean±SD). (C) Bik expression leads to cell death inWTbut not DKO cells. As in B, but cellswere
the indicated times was determined by Western blot with an anti-HA antibody, and is shownand visualized by enhanced chemiluminescence (Amersham). Pri-
mary antibodies used for Western blots were: mouse anti-HA,
mouse anti-tubulin (Sigma), and mouse anti-actin (ICN
Biomedicals).(A) Schematic representation of Bap31 and p20 domains and topology at the ER. Caspase
thoughwith delayed kinetics in theDKO cells. Cellswere infectedwith either AdHA-p20 or
CS analysis of PI uptake. Results are presented as the percentage of PI positive cells (n=3,
infectedwithAdHA-Bik instead of AdHA-p20. Expression ofHA-p20 (B) andHA-Bik (C) at
below the corresponding graph. Actin was used as a loading control.
Fig. 2. Characterization of p20-initiated cell death in WT and DKO BMK cells. (A) p20
leads to caspase activation in both WT and DKO cells, although with delayed kinetics
in the DKO cells. Cells were infected with AdHA-p20 for the indicated times, and effec-
tor caspase activity was determined by the ability of cell lysates to hydrolyze the
ﬂuorogenic caspase substrate DEVD-amc (n=3, mean±SD). (B) Caspase inhibition
only slightly delays cell death, in both WT and DKO cells. Cells were infected with
AdHA-p20 for the indicated times, in the presence or absence of zVAD-fmk. Viability
was determined by FACS analysis of PI uptake, and results are presented as the percent-
age of PI positive cells (n=3, mean±SD). (C) ER Ca2+ levels show an initial increase,
followed by delayed depletion, in both WT and DKO cells. Cells were infected with
AdHA-p20 for the indicated times, loaded with Fura2-AM in Ca2+-free buffer, and ER
Ca2+ stores were determined based on the increase in Fura2 ﬂuorescence following
the addition of TG (n=3, mean±SD).
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3.1. Ectopic expression of p20 leads to cell death even in the absence of
Bax/Bak
Bap31 is a 246 amino acid ER localized protein with three pre-
dicted TM domains, a luminal N-terminal (N-T) domain, and a
coiled-coil cytosolic C-terminal (C-T) domain (Fig. 1a). The C-T do-
main terminates with a canonical ER retrieval motif (KKEE). This
motif, however, does not seem to be required for ER localization, as
a truncated form of Bap31, lacking the KKEE motif, remains localized
to the ER [1]. The C-T region of Bap31 also contains a variant death ef-
fector domain (vDED) ﬂanked by two caspase 8/1 recognition sites, at
aspartate 164 and 238. Although mouse Bap31 lacks the distal cas-
pase recognition site, the protein is highly conserved, with 95% se-
quence identity between human and mouse [38]. Caspase cleavage
at asp164 generates the p20 fragment in both mouse and human
(Fig. 1a).
A number of apoptotic stimuli generate the proapoptotic p20 frag-
ment, and we have previously shown, using a variety of human and
murine cell lines, that ectopic expression of p20 triggers a proapopto-
tic pathway initiated by rapid depletion of ER Ca2+ stores [15]. We
have also shown that the ER localized BH3-only protein Bik initiates
a similar pathway, in which early ER Ca2+ release is dependent on
Bax/Bak [34,35]. In order to determine the role of Bax/Bak in the
p20-initiated pathway, we used WT and Bax/Bak DKO BMK cells, im-
mortalized through transformation with E1A and DN p53 (hereafter
referred to as WT and DKO cells). Using an adenoviral delivery sys-
tem, we found that HA-tagged p20 (HA-p20) induces cell death, as
measured by PI uptake, in both WT and DKO cells, although with
delayed kinetics in the DKO cells (Fig. 1b). As expected based on pre-
vious studies [35], Bik mediated cell death was completely inhibited
in the absence of Bax/Bak (Fig. 1c). As a negative control, WT and
DKO cells were infected with adenovirus expressing the protein rtTa
(Fig. 1b). No signiﬁcant cell death was seen in the negative control,
at up to 72 h post-infection for DKO cells, and at up to 24 h post-
infection for WT cells. Expression levels of HA-p20 and HA-Bik in
both WT and DKO cells are shown in Fig. 1b, c. Note that higher levels
of both p20 and Bik can be tolerated in the absence of Bax/Bak.
3.2. Characterization of a novel, Bax/Bak independent, p20-initiated cell
death pathway
The ability of HA-p20 (but not HA-Bik) to kill cells even in the ab-
sence of Bax/Bak points to an important difference between the p20
and Bik initiated pathways, and to a novel, Bax/Bak independent, p20-
initiated mode of cell death. In order to further characterize this novel
p20-initiated pathway,we looked at caspase activity and ER Ca2+ levels;
cell death in response to either p20 or Bikwas previously reported to in-
volve both caspase activation and an early release of ER Ca2+ stores
[15,34,35,37]. Surprisingly, although caspase activity was observed in
bothWT andDKO cells, incubationwith the broad-spectrum caspase in-
hibitor zVAD-fmk did not signiﬁcantly delay death in either cell line
(Fig. 2a,b). Effective inhibition of executioner caspases-3 and 7 by
zVAD-fmk was veriﬁed using a DEVDase activity assay (data not
shown). Furthermore, p20 did not lead to the expected early release of
ER Ca2+ stores, but rather to an initial rise in ER Ca2+, followed by
slow release, again in both WT and DKO cells (Fig. 2c). These results in-
dicate that p20 can initiate more than one type of cell death. The ﬁrst,
previously characterized, type of cell death is dependent on both early
release of ER Ca2+ and on caspase activity. The second type of cell
death, described here, is independent of caspase activity, and involves
an early rise in ER Ca2+ stores.
As the p20-induced pathway seen in this system appeared distinct
from that previously described, we attempted to determine the early,
or initiating, events. In this context, we found that the earliestobservable effect of p20 was a dramatic cytosolic vacuolization,
which occurred soon after p20 expression, in both WT and DKO
cells (Fig. 3a, b). Vacuolization appeared to result from extensive
remodeling of the ER, as shown by immunoﬂuorescent visualization
using the ER marker calnexin (Fig. 3c). p20 was localized to the ER
(as expected based on previous reports [15]), and both remodeling
and “clumping” of the ER could be detected through visualization of
Fig. 3. Early p20-initiated changes in cell morphology. (A) Phase contrast images of early p20-initiated morphological changes. DKO (upper) andWT (lower) cells were infected with AdrtTa
(control, left panels) orAdHA-p20 (right panels) for 12 h. The arrow indicates vacuolization in ap20-expressing cell. (B) Immunoﬂuorescent visualizationof p20-initiated cytosolic vacuolization
in DKO cells. Cells were either left untreated, or infected with Ad-HAp20 for 20 h, and cytosol was visualized using an anti-LDH antibody. (C) Immunoﬂuorescent visualization of p20-initiated
changes in ERmorphology. DKO (upper) andWT (lower) cells were infectedwith AdrtTa (control, left panels) or AdHA-p20 (right panels) for 10 h, and ERwas visualized using an antibody to
the integral ERmembrane protein calnexin (cnx). Areas of both ER vacuolization (star) and aggregation (arrow) can be seen in p20 expressing cells. (D) ER localization of HA-p20. DKO (upper)
andWT (lower) cells were infectedwith AdHA-p20 for 10 h. HA-p20was visualized via stainingwith an anti-HA antibody, and calnexinwas used as an ERmarker. HA-p20 is shown in the left
panel, cnx is shown in the center panel, and an overlay of the left and center panels is shown in the right panel. All infections were done at an MOI of 40.
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sion on organelle morphology was also examined using electron mi-
croscopy (Fig. 4). Electron micrographs of AdHA-p20 infected cells
showed progressive dilation of the ER and NE, ultimately leading to
dramatic cellular vacuolization, in both DKO (Fig. 4a) and WT (not
shown) cells. Mitochondria appeared either normal, condensed or
swollen, but did not show the cristae remodeling characteristic of
Bik-initiated ER Ca2+ transmission to this organelle [34]. Both WT
and DKO cells yielded evidence of necrosis in response to p20, with
observations of organelle swelling and plasma membrane rupture,
in the absence of typical apoptotic morphology (chromatin condensa-
tion, cell shrinkage, blebbing) (Fig. 4a). In some cases there was also
evidence of ampliﬁed, organized smooth ER (OSER), which seemedFig. 4. Early p20-initiated changes in cell morphology visualized by electron microscopy. (
transformed BMK cells. DKO cells were either untreated (i) or infected with AdHA-p20 at a
pansion of the ER in an AdHA-p20 infected DKO cell. Although swollen, the reticular structur
AdHA-p20 infected cell. (iv) Higher magniﬁcation of the cell in (iii) showing a dilated nuclea
extensive ER remodeling. (vi) Apparent necrosis of an AdHA-p20 infected cell involving plas
or swollen appearance of mitochondria, as well as the dramatic vacuolization of the ER/NE.
following infection with AdHA-p20 for 12 h, at an MOI=80.to be generated within vacuolated ER/NE (Fig. 4b). OSER arises due
to overexpression of dimerization competent ER membrane proteins,
and can be seen as bright spots (i.e. “clumping”) in immunoﬂuores-
cent images (Fig. 3c, d) [41].
3.3. Effect of ER-restricted Bcl2 on p20-initiated events in DKO cells
Based on the previously reported ability of both WT and ER-
restricted Bcl2 to inhibit p20-initiated apoptosis [15], as well as the
fact that Bcl2 can also, in some cases, inhibit non-apoptotic cell
death [42–51], we chose to examine the effect of ER-restricted Bcl2
on the p20-initiated pathway in DKO cells. In order to do this, we gen-
erated DKO cells stably expressing an HA-tagged, ER-restricted formA) Representative images of the phenotypic effects of p20 expression on E1A/DNp53
n MOI of 40 (ii–vi). (i) An untreated DKO cell with normal ER (arrow). (ii) Modest ex-
e of the ER is still visible (arrow). (iii) Extensive swelling/remodeling of the ER/NE in an
r pore. (v) Apparently normal mitochondrial ultrastructure (arrow), in the presence of
ma membrane rupture (arrows). Note the lack of chromatin condensation, and normal
(B) p20-induced formation of organized smooth ER (OSER, arrow) in a DKO BMK cell,
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Bcl2b5 was able to delay both p20-associated cell death and ER/NE
vacuolization in the DKO cells (Fig. 5). It should be noted, however,Fig. 5. ER-restricted Bcl2 delays both cell death and ER remodeling in the absence of Bax/Ba
DKO/HA-Bcl2b5 cells were infected with AdHA-p20, at an MOI of 80, for the indicated times,
percentage of PI positive cells (n=3, mean±SD). Note that DKO cells began to die between
HA-Bcl2b5 cells until at least 48 h after infection (arrows). Expression of HA-p20 in either DK
an anti-HA antibody, as shown in the lower panel. Tubulin was used as a loading control. (B)
DKO/HA-Bcl2b5 (right) cells were infected with AdHA-p20 (MOI=40), and representative
Note the decreased level of vacuolization in DKO/HA-Bcl2b5 cells at 10.5 h, and the lower lev
of the effect of Bcl2b5 on p20-initiated ER expansion in DKO cells. (i) Representative picture
HA-Bcl2b5 cells. (ii) Quantiﬁcation of ER remodeling in DKO and DKO/HA-Bcl2b5 cells, via d
for 12 h, at an MOI=40.that the protective effects of Bcl2b5 were ultimately overwhelmed
in the face of increasing expression levels of p20 (Fig. 5a). The effect
of Bcl2b5 on p20-initiated ER dilation could be seen using both lightk. (A) ER-restricted Bcl2 (Bcl2b5) delays p20-initiated cell death in DKO cells. DKO or
and viability was determined by FACS analysis of PI uptake. Results are presented as the
24 and 36 h after infection with AdHA-p20, while no cell death was observed in DKO/
O or DKO/HA-Bcl2b5 cells at the indicated times was determined byWestern blot with
Bcl2b5 delays p20-initiated vacuolization and detachment of DKO cells. DKO (left) and
images were acquired at 10.5 h (upper panels) and 24 h (lower panels) after infection.
el of both vacuolization and detachment at 24 h. (C) Electron microscopic visualization
s of untreated (left column) and AdHA-p20 infected (right column) WT, DKO, and DKO/
etermination of the percentage of cellular area taken up by vacuolated ER. Infection was
342 H.M. Heath-Engel et al. / Biochimica et Biophysica Acta 1823 (2012) 335–347microscopy (Fig. 5b) and EM (Fig. 5c). Results from an EM experiment
were quantiﬁed via determination of percentage cellular area occu-
pied by vacuolated ER/NE (Fig. 5c).
A direct interaction between Bcl2 and p20 was previously
reported [38] and the established cytoprotective role of Bcl2 depends
on binding and sequestration of proapoptotic proteins [30,52,53]. A
potential interaction between Bcl2b5 and p20 in the DKO cells was
therefore investigated using co-immunoprecipitation, and the role
of the Bcl2b5 BH3 binding pocket was addressed using the small mol-
ecule BH3 mimetic ABT-737 [54,55]. If the protective effect of Bcl2b5
required the Bcl2 binding pocket, ABT-737 would be expected to pro-
vide a sensitizing effect. We choose to look at the effect of ABT-737 on
cell death in DKO/HA-Bcl2b5 cells at 48 h after infection with AdHA-
p20; a time at which a signiﬁcant proportion of DKO, but not DKO/
HA-Bcl2b5 cells, were PI positive (Fig. 5a). Using the above-
described techniques we found that, in the DKO/HA-Bcl2b5 cells, no
interaction could be detected between HA-p20 and HA-Bcl2b5
(Fig. 6a), and, in addition, that ABT-737 was unable to overcome the
protective effect of Bcl2b5 with respect to p20 (Fig. 6b). In these
E1A/DNp53 transformed BMK cells, Bcl2b5 therefore provides a Bax/
Bak independent protective effect, which, based on the results pre-
sented in Fig. 6, is likely independent of direct interaction with p20,
and of the BH3 binding pocket.
One function of Bcl2 that does not depend on either the BH3 bind-
ing pocket or on Bax/Bak is that of regulation of ER Ca2+ stores
[56,57]. As p20-initiated death in both WT and DKO cells was charac-
terized by an early rise in ER Ca2+ stores, and Bcl2 has been reported
to lower ER Ca2+ content [15,58–60], we hypothesized that the pro-
tective effect of Bcl2b5 could be due to decreased ER Ca2+, and, fur-
thermore, that intact ER Ca2+ stores might be required for p20-Fig. 6. The effect of Bcl2b5 on the p20-initiated pathway in DKO cells does not involve eithe
(A) There is no detectable interaction between HA-Bcl2b5 and HA-p20 in DKO cells. DKO/H
(positive control, MOI=25). Cells were disrupted using IP buffer (0.1% Triton X-100, 0.5% N
antibody, or NHS (control). 200 μg of each IP, along with 20 μg (10%) of input, was analyzed
(B) The small molecule BH3 mimetic ABT-737 does not affect HA-p20 initiated death in DKO
or AdrtTA (control, MOI=80), in the presence of either 1 μMABT-737 or DMSO (vehicle), an
presented as the percentage of PI positive cells above that present in the negative (untreated
737, was determined by Western blot with an anti-HA antibody, following a 12 infection winduced ER/NE dilation. Consistent with this hypothesis, we found
that ER Ca2+ stores were in fact lower in DKO/HA-Bcl2b5 cells than
in DKO cells (Fig. 7a). In addition, we found that depletion of ER Ca2+
storeswith a low concentration of thapsigargin (TG) prior to expression
of p20 signiﬁcantly decreased the number of cells with remodeled ER
(Fig. 7b). These results indicate that intact ER Ca2+ stores are likely re-
quired for p20-mediated disruption of ER structure, and that the protec-
tive effect of Bcl2b5 may be due to modulation of ER Ca2+.3.4. ER remodeling can be initiated by overexpression of full-length
Bap31, but not of other ER TM proteins
The ER/NE vacuolization seen in response to p20 is highly reminis-
cent of that seen in certain forms of ER stress [61–74], and p20 has
been reported to interfere with protein trafﬁcking in several systems,
likely through a dominant negative effect on full-length Bap31 [1,4,9].
If dysregulation of Bap31-mediated protein trafﬁcking underlies cell
death in this system, then a similar effect might be seen following
overexpression of the full-length protein. This was in fact the case,
as overexpression of Bap31 also resulted in ER remodeling. This was
not due to caspase cleavage of the full-length protein following ex-
pression, as a caspase-resistant form of Bap31 (crBap31) also led to
disruption of ER structure (Fig. 8a). Bap31/p20 initiated ER dilation
was not a nonspeciﬁc effect of overexpression of an ER TM protein,
as normal morphology was maintained following overexpression of
the polytopic ER TM protein A4 [75] (Fig. 8b). Both p20 and A4
were tagged with HA, and were overexpressed to comparable levels.
Similar results to those shown for A4 were observed following over-
expression of the ER TM proteins Derlin-1 and calnexin (not shown).r a detectable interaction between the two proteins or the Bcl2b5 BH3 binding region.
A-Bcl2b5 cells were infected overnight with either AdHA-p20 (MOI=40) or AdHA-Bik
P40), and 800 μg of whole cell lysate was subjected to IP with either hamster anti-hBcl2
by Western blot with an anti-HA antibody, to detect HA-p20, HA-Bik, and HA-Bcl2b5.
/HA-Bcl2b5 cells. DKO/HA-Bcl2b5 cells were infected with either AdHA-p20 (MOI=80)
d viability was determined by FACS analysis of PI uptake 48 h after infection. Results are
) control (n=3, mean±SD). Expression of HA-p20, in the presence or absence of ABT-
ith AdHA-p20 at an MOI of 80. Tubulin was used as a loading control.
Fig. 7. Bcl2b5 lowers ER Ca2+ stores in DKO cells, and intact ER Ca2+ stores are required
for p20-initiated ER remodeling. (A) ER Ca2+ stores are lower in DKO/HA-Bcl2b5 cells
than in DKO cells. Cells were loaded with Fura2-AM in Ca2+-free buffer, and ER Ca2+
stores were determined based on the increase in Fura2 ﬂuorescence following the ad-
dition of TG (n=3, mean±SD). (B) Intact ER Ca2+ stores are required for p20-initiated
ER remodeling. ER Ca2+ stores in DKO cells were depleted using a low (50 nM) concen-
tration of TG prior to infection with AdHA-p20 (MOI=40, 16 h), and ER structure was
visualized through immunoﬂuorescent detection of HA-p20 with an anti-HA antibody.
The percentage of cells with remodeled ER was determined by visual inspection and
quantiﬁcation, and at least 200 cells per condition were examined for each experiment
(n=4, mean±SD). Inset shows representative immunoﬂuorescence images of HA-
p20 expressing cells, with and without TG. The lower panel shows the expression
level of HA-p20, in the presence and absence of TG, as determined by Western blot
with an anti-HA antibody. Actin was used as a loading control.
343H.M. Heath-Engel et al. / Biochimica et Biophysica Acta 1823 (2012) 335–3474. Discussion
4.1. Identiﬁcation of a novel p20 initiated, Bax/Bak independent, cell
death pathway
Both p20 and the ER localized BH3-only protein Bik were previ-
ously shown to provide a sensitizing signal with respect to Bax/Bak
associated mitochondrial apoptosis, dependent on an early release
of ER Ca2+ stores and on ER–mitochondria Ca2+ transmission
[15,34,35]. We have now uncovered a second p20-initiated pathway,
wherein, in the absence of early ER Ca2+ release, p20 expression leads
to non-apoptotic cell death, associated with dramatic dilation of the
ER/NE. Of note, this second pathway was not initiated by ectopic ex-
pression of Bik, pointing to an important difference in the mode of ac-
tion of these two proteins.
Cell death in this system, in spite of detectable caspase activity, could
not be inhibited by zVAD-fmk (a broad spectrum caspase inhibitor). In
addition, EM analysis of dying cells showed evidence of necrosis(organelle swelling and plasmamembrane rupture), but not of apoptosis
(nuclear condensation, cell shrinkage, blebbing), or of the mitochondrial
cristae remodeling associated with Bik-initiated Ca2+ transmission [34].
The earliest observable effect of p20 expression, in both WT and Bax/
BakDKO BMK cells, was a dramatic vacuolization of the ER/NE, accompa-
nied by a rise in ERCa2+ stores. ER/NEdilationwas apparently dependent
on intact ER Ca2+ stores, as depletion of ER Ca2+ via pretreatment with a
low concentration of TG signiﬁcantly decreased the number of cells dis-
playing ER/NE remodeling.
The above-described changes in ER/NE morphology are similar to
those seen during paraptosis: a caspase-independent, non-apoptotic,
form of programmed cell death culminating in necrosis [51,74,76–83].
Paraptosis, although poorly deﬁned at the molecular level, is character-
ized by progressive organelle, primarily ER, vacuolization [76,82,84]. Of
potential signiﬁcance, a paraptosis-like form of cell death is often seen
in response to ER stressors, in particular those involving both increased
accumulation of misfolded proteins and inhibition of ERAD
[61–65,67–74,81,85]. Although p20 has been shown to initiate early ER
Ca2+ release and downstream mitochondrial alterations in several cell
types [15], it has also been shown to interfere with protein trafﬁcking,
possibly via a dominant negative effect on full length Bap31 [1,4,9]. As
Bap31 plays a role in both ERAD [9,10] and protein export from the ER
[4,6,7], it is conceivable that disruption of Bap31 dependent protein traf-
ﬁcking (in this case through expression of p20) could lead to both in-
creased protein load within the ER, and a block in degradation.
It therefore appears that in certain cell types or under certain con-
ditions, p20 does not trigger ER Ca2+ release, but instead stimulates
paraptosis-like cell death, possibly via ER stress. Why some cell
types release ER Ca2+ in response to p20 while the E1A/DNp53 trans-
formed cells used here do not, however, remains to be determined.
The fact that the SERCA inhibitor thapsigargin readily stimulated re-
lease of ER Ca2+ stores in these BMK cells and indeed such release
of ER Ca2+ protected against p20-induced ER changes (Fig. 7) sug-
gests that the Ca2+ release channel is functional, and that for reasons
that remain to be elucidated p20 is incapable of coupling to such re-
lease, in contrast to KB and H1299 cells.
Whether or not the paraptosis-like cell death observed in this system
stems from the inﬂuence of p20 on ER protein trafﬁcking also remains to
be determined. It is, however, noteworthy that over-expression of full
length Bap31, but not of other integral ER proteins, also caused ER remo-
deling in the E1A/DNp53-transformed BMK cells. Moreover, the ER
remodeling induced by over-expression of Bap31 or crBap31 was also
associated with cell toxicity (data not shown).
Based on the above evidence, we propose that p20 can initiate two
distinct pro-death pathways, dependent on the underlying physiolo-
gy of the cell type under study (Fig. 9). The ﬁrst of these, which was
previously described [15], is proapoptotic, involves an early release
of ER Ca2+ stores, and provides a sensitizing effect with respect to
Bax/Bak dependent mitochondrial release of cytochrome c. The sec-
ond pathway, described herein for the ﬁrst time, is characterized by
an initial rise, as opposed to release, of ER Ca2+ stores, and involves
a dramatic dilation of the ER/NE. This pathway ultimately results in
non-apoptotic cell death, potentially due to disruption of ER homeo-
stasis. The early events in this pathway, including increased ER Ca2+
content and ER/NE dilation, are apparently independent of Bax/Bak;
occurring at about the same time in both WT and DKO cells. The
later events, including caspase activity and loss of membrane integri-
ty, can be delayed, but not completely inhibited, by the loss of Bax/
Bak. Bax/Bak therefore appear to accelerate execution, but not initia-
tion, of this form of cell death.
It should be noted that Bax/Bak deﬁcient cells were previously
shown to display lowered ER Ca2+ stores [86]. Based on the apparent
dependence of p20 initiated ER remodeling on intact ER Ca2+ stores,
ER remodeling, in addition to ultimate cell death, should be delayed
in the absence of Bax/Bak. Although onset of ER dilation appeared to
occur at approximately the same time, and to the same extent, in
Fig. 8. Overexpression of full length Bap31, but not of the integral ER membrane protein A4, leads to ER remodeling in DKO cells. (A) Overexpression of either Bap31 or crBap31
results in ER remodeling. DKO cells were transiently transfected with either Flag-Bap31 or Flag-crBap31 for 20 h, and ER was visualized by staining with an anti-Flag antibody.
(B) Overexpression of the polytopic ER TM protein A4 does not affect ER morphology. DKO cells were transiently transfected with either HA-p20 (upper panel) or HA-A4
(lower panel) for 11 h, and ER was visualized by staining with both an anti-HA antibody (left) and an anti-cnx antibody (right). Expression levels of HA-p20 and HA-A4 were de-
termined by Western blot with an anti-HA antibody. Tubulin was used as a loading control.
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and 5), the precise timing of this event was not determined. It is
therefore possible that the loss of Bax/Bak did in fact provide a slight
delay in the onset of ER dilation. Alternatively, the reduction in ER Ca2+
stores as a result of Bax/Bak deletion may not have been sufﬁcient to
provide a protective effect in this system.
Another interesting feature of the p20 death pathway described
here is that effector caspases were activated by p20, yet cell death was
by a paraptosis-like mechanism, and pan-caspase inhibition by zVAD-
fmkwaswithout effect. Thus, there is an apparent block between effec-
tor caspase activation and the ability to execute apoptosis in a time
frame that would precede the paraptosis response. In future studies it
will be intriguing to determine if this is linked to the defect in Ca2+ re-
lease by p20. Caspase activation was a late event, occurring well after
both ER dilation and the rise in ER Ca2+ stores, and at approximately
the same time as loss of viability (Figs. 1–3). Furthermore, both loss of
mitochondrial membrane potential and cytochrome c release (indicat-
ing loss of mitochondrial integrity) were seen at approximately the
same time as capsase activity was ﬁrst observed (data not shown). Cas-
pase activationmay therefore, in this case, be a consequence of general-
ized disruption of organelle structure, which, as a result of
mitochondrial membrane permeabilization and/or rupture, would
lead to cytochrome c dependent caspase activation, concurrentwith ne-
crotic cell death. In support of this hypothesis, there is a growing body of
evidence indicating thatmultiple cell death pathways are often initiatedin concert, and that caspase inhibition, inmany cases, is not sufﬁcient to
inhibit ultimate cell death [84,87,88].
4.2. Effect of ER-restricted Bcl2 on the p20-initiated pathway in DKO
BMK cells
Bcl2 can inhibit a variety of apoptotic pathways, and, in most
cases, is thought to act through inhibition of Bax/Bak [29]. Bcl2 has
also, however, been reported to inhibit non-apoptotic cell death
[42–51], and can function independently of Bax/Bak, as shown with
respect to its role in ER Ca2+ handling [56]. As both WT and ER-
restricted Bcl2 were able to inhibit the proapoptotic p20-initiated
pathway [15], we decided to investigate the effect of Bcl2b5 on non-
apoptotic p20-associated cell death in DKO BMK cells. We found
that Bcl2b5 was able to signiﬁcantly delay both cell death and ER/
NE vacuolization in the absence of Bax/Bak. This effect of Bcl2b5 did
not appear to involve the BH3 binding pocket, and no interaction
could be detected between Bcl2b5 and p20. Based on these observa-
tions, in combination with the observed decrease in ER Ca2+ stores
in the presence of Bcl2b5, and the importance of intact ER Ca2+ stores
in p20-initiated ER dilation, we propose that the protective effect of
Bcl2b5 in this system is likely due to modulation of ER Ca2+ levels.
Bcl2 is frequently overexpressed in various malignancies, and sensiti-
zation of tumor cells to apoptosis via Bcl2 inhibition using BH3 mi-
metics is currently a topic of active research [55]. Evidence for Bcl2
Fig. 9. Proposed model for p20 initiated cell death pathways. Pathway 1 refers to the
previously described p20 initiated pathway, and Pathway 2 refers to the novel p20 ini-
tiated pathway described in this paper. See text for details.
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Bax/Bak and of the BH3 binding pocket, therefore has potentially im-
portant clinical implications.
In conclusion,we have identiﬁed a Bax/Bak independent paraptosis-
like cell death pathway initiated by expression of p20 (Fig. 9). Early
events in this pathway include a rise in ER Ca2+ stores, as well as dra-
matic dilation of the ER/NE. We propose that this pathway reﬂects
p20/Bap31-mediated disruption of ER homeostasis in susceptible cell
types. Of particular importance, both p20-initiated cell death and initial
ER dilation could be signiﬁcantly delayed by overexpression of ER-
restricted Bcl2 in the DKO cells. This ability of ER localized Bcl2 to inhibit
Bax/Bak independent non-apoptotic cell deathmay have important im-
plicationswith respect to the design and implementation of therapeutic
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